Acadia Healthcare (NASDAQ:ACHC) Hits New 52-Week Low - Time to Sell?

Key Points

• Acadia Healthcare's stock reached a new 52-week low at $19.94, down 18.1%, with a significant trading volume of 438,163 shares.
• Recent analyst updates include upgrades from "sell" to "hold" ratings by Wall Street Zen and Stephens, while Guggenheim set a "buy" rating with a target price of $36.00.
• The company posted a quarterly EPS of $0.83, exceeding analysts' estimates, with a year-over-year revenue increase of 9.2%, reaching $869.23 million.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $20.29 and last traded at $19.94, with a volume of 438163 shares trading hands. The stock had previously closed at $21.76.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ACHC. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Cowen restated a "buy" rating on shares of Acadia Healthcare in a research report on Thursday. KeyCorp reduced their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Stephens upgraded Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, Guggenheim dropped their price target on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research report on Thursday. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $44.75.

Acadia Healthcare Stock Up 5.7%

The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a market capitalization of $1.78 billion, a PE ratio of 12.74, a P/E/G ratio of 3.74 and a beta of 0.88. The company has a 50-day moving average price of $22.18 and a 200 day moving average price of $27.65.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. The firm had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. During the same quarter last year, the business posted $0.91 earnings per share. The business's quarterly revenue was up 9.2% compared to the same quarter last year. Analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently bought and sold shares of the business. FMR LLC increased its holdings in shares of Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after buying an additional 4,489,681 shares during the last quarter. Citigroup Inc. increased its stake in Acadia Healthcare by 5,144.2% during the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock worth $72,047,000 after acquiring an additional 2,330,898 shares during the last quarter. Hawk Ridge Capital Management LP increased its stake in Acadia Healthcare by 437.5% during the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock worth $74,988,000 after acquiring an additional 2,013,126 shares during the last quarter. Madison Avenue Partners LP bought a new stake in Acadia Healthcare during the fourth quarter worth approximately $76,339,000. Finally, Abrams Bison Investments LLC bought a new stake in Acadia Healthcare during the first quarter worth approximately $55,182,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.